Blue Jet Healthcare Limited (BOM:544009)

Market Cap	153.34B
Revenue (ttm)	10.30B
Net Income (ttm)	3.05B
Shares Out	n/a
EPS (ttm)	17.59
PE Ratio	50.24
Forward PE	40.59
Dividend	1.00 (0.11%)
Ex-Dividend Date	Sep 17, 2024

Volume	18,071
Average Volume	24,215
Open	879.95
Previous Close	871.80
Day's Range	861.80 - 881.70
52-Week Range	394.40 - 985.60
Beta	n/a
RSI	51.49
Earnings Date	May 30, 2025

About Blue Jet Healthcare

Blue Jet Healthcare Limited engages in the manufacturing and sale of pharmaceutical intermediates and active pharmaceutical ingredients (APIs) for use in pharmaceutical and healthcare products. It provides contrast media intermediates; niche pharmaceutical intermediates and APIs; and CDMO/CMO services, as well as end-to-end solutions from process development and commercialization of NCEs, advance intermediates, API, and building blocks. The company develops, manufactures, and markets saccharin and related salts. It has operations in India, Norw...

• Industry: Pharmaceutical Preparations
• Founded: 1968
• Employees: 447
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544009

Financial Performance

In 2024, Blue Jet Healthcare's revenue was 10.30 billion, an increase of 44.74% compared to the previous year's 7.12 billion. Earnings were 3.05 billion, an increase of 86.38%.